DK143554C - Fremgangsmaade til fremstilling af 1-t-butylamino-3-(2,5-diklorfenoxy)-2-propanol eller et syreadditionssalt deraf - Google Patents

Fremgangsmaade til fremstilling af 1-t-butylamino-3-(2,5-diklorfenoxy)-2-propanol eller et syreadditionssalt deraf

Info

Publication number
DK143554C
DK143554C DK88577A DK88577A DK143554C DK 143554 C DK143554 C DK 143554C DK 88577 A DK88577 A DK 88577A DK 88577 A DK88577 A DK 88577A DK 143554 C DK143554 C DK 143554C
Authority
DK
Denmark
Prior art keywords
dichlorphenoxy
butylamino
propanol
preparing
acid addition
Prior art date
Application number
DK88577A
Other languages
Danish (da)
English (en)
Other versions
DK143554B (da
DK88577A (da
Inventor
A Hajos
M Fekete
M Kuerti
T Lang
L Toldy
J Borvendeg
L Nagy
S Elek
I Polgari
I Elekes
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of DK88577A publication Critical patent/DK88577A/da
Publication of DK143554B publication Critical patent/DK143554B/da
Application granted granted Critical
Publication of DK143554C publication Critical patent/DK143554C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK88577A 1976-03-02 1977-03-01 Fremgangsmaade til fremstilling af 1-t-butylamino-3-(2,5-diklorfenoxy)-2-propanol eller et syreadditionssalt deraf DK143554C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUGO001331 1976-03-02
HU76GO00001331A HU172137B (hu) 1976-03-02 1976-03-02 Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina

Publications (3)

Publication Number Publication Date
DK88577A DK88577A (da) 1977-09-03
DK143554B DK143554B (da) 1981-09-07
DK143554C true DK143554C (da) 1982-03-08

Family

ID=10996805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK88577A DK143554C (da) 1976-03-02 1977-03-01 Fremgangsmaade til fremstilling af 1-t-butylamino-3-(2,5-diklorfenoxy)-2-propanol eller et syreadditionssalt deraf

Country Status (25)

Country Link
US (1) US4310549A (xx)
JP (1) JPS5923299B2 (xx)
AT (1) AT348507B (xx)
AU (1) AU508766B2 (xx)
BE (1) BE851938A (xx)
CA (1) CA1091254A (xx)
CH (1) CH627732A5 (xx)
CS (1) CS190340B2 (xx)
DD (1) DD128610A5 (xx)
DE (1) DE2709109C3 (xx)
DK (1) DK143554C (xx)
FI (1) FI65231C (xx)
FR (1) FR2342956A1 (xx)
GB (1) GB1573191A (xx)
HU (1) HU172137B (xx)
IL (1) IL51574A (xx)
IN (1) IN144243B (xx)
KE (1) KE3340A (xx)
MY (1) MY8500104A (xx)
NL (1) NL7702170A (xx)
NO (1) NO141989C (xx)
PL (1) PL103734B1 (xx)
SE (1) SE440647B (xx)
SU (1) SU648080A3 (xx)
YU (1) YU40813B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110117731A (ko) * 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
WO2008010087A2 (en) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH569692A5 (xx) 1971-03-17 1975-11-28 Richter Gedeon Vegyeszet
US4067904A (en) * 1975-12-19 1978-01-10 Mead Johnson & Company Alkylsulfonylphenoxypropanolamine derivatives

Also Published As

Publication number Publication date
IL51574A0 (en) 1977-05-31
GB1573191A (en) 1980-08-20
HU172137B (hu) 1978-06-28
PL103734B1 (pl) 1979-07-31
ATA134177A (de) 1978-07-15
DK143554B (da) 1981-09-07
FI65231C (fi) 1984-04-10
YU40813B (en) 1986-06-30
AU508766B2 (en) 1980-04-03
FI770651A (xx) 1977-09-03
SE7702251L (sv) 1977-09-03
NO770688L (no) 1977-09-05
NO141989C (no) 1980-06-11
CA1091254A (en) 1980-12-09
DE2709109A1 (de) 1977-09-15
NO141989B (no) 1980-03-03
US4310549A (en) 1982-01-12
AT348507B (de) 1979-02-26
IN144243B (xx) 1978-04-15
YU54977A (en) 1982-10-31
DD128610A5 (de) 1977-11-30
MY8500104A (en) 1985-12-31
FI65231B (fi) 1983-12-30
KE3340A (en) 1983-11-25
IL51574A (en) 1980-01-31
FR2342956B1 (xx) 1982-11-26
CH627732A5 (de) 1982-01-29
FR2342956A1 (fr) 1977-09-30
CS190340B2 (en) 1979-05-31
SU648080A3 (ru) 1979-02-15
DE2709109B2 (de) 1980-01-17
DK88577A (da) 1977-09-03
JPS52122328A (en) 1977-10-14
JPS5923299B2 (ja) 1984-06-01
DE2709109C3 (de) 1980-09-18
AU2279577A (en) 1978-09-07
SE440647B (sv) 1985-08-12
BE851938A (fr) 1977-09-01
NL7702170A (nl) 1977-09-06

Similar Documents

Publication Publication Date Title
DK144010C (da) Analogifremgangsmaade til fremstilling af 2-piperazinyl-6,7-dimethoxyquinazoliner eller syreadditionssalte deraf
DK462380A (da) Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf
DK150512C (da) Analogifremgangsmaade til fremstilling af 3-quino-lincarboxylsyrederivater eller syreadditionssalte deraf
DK392877A (da) Fremgangsmaade til fremstilling af phenylethylaminer eller syreadditionssalte heraf
DK149963C (da) Fremgangsmaade til fremstilling af 2,5-diketo-d-gluconsyre eller et saltderaf
DK453181A (da) Fremgangsmaade til fremstilling af 2-quanidino-4-heteroaryl-thiazolforbindelser eller syreadditionssalte deraf
NL7902408A (nl) 3,7-digesubstitueerde-3-cefem-4-carbonzuurverbindingen en werkwijzen ter bereiding daarvan.
DK413783A (da) Fremgangsmaade til fremstilling af 20-amino-macrolidderivater eller syreadditionssalte deraf
DK144944C (da) Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf
AR224997A1 (es) Metodo para preparar 5-benzoil o 5-benzoil sustituido derivados de acidos 1,2-dihidro-3h-pirrolo(1,2-a)pirrol-1-carboxilicos
DK75878A (da) Fremgangsmaade til fremstilling af 20,21,-di-noreburnameninderivater eller additionssalte deraf
DK134580A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK430379A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK148281C (da) Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf
DK155081A (da) Fremgangsmaade til fremstilling af 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaensyre eller salte heraf
DK142578C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-5-benzylpyrimidiner og syreadditionssalte deraf
DK143554C (da) Fremgangsmaade til fremstilling af 1-t-butylamino-3-(2,5-diklorfenoxy)-2-propanol eller et syreadditionssalt deraf
DK144916C (da) Fremgangsmaade til fremstilling af vlb-3-spiro-5"-oxazolidin-2",4"-dion eller ikke-toxiske syreadditionssalte heraf
DK154085C (da) Fremgangsmaade til fremstilling af 1,1-dioxopenicillansyrederivater
DK138265B (da) Analogifremgangsmåde til fremstilling af 4,4-diaryl-2-hydroxybutylaminer eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK148036C (da) Analogifremgangsmaade til fremstilling af epimere 4''-amino-erythromycin-forbindelser eller syreadditionssalte deraf
DK260080A (da) Fremgangsmaade til fremstilling af 2-amino-alkyl5-phenyl-hexahydro-trans-4a,9b-pyrido (4,3-b)indoler eller syreadditionssalte deraf
DK153539C (da) Fremgangsmaade til fremstilling af 3,3-dimethyl-2-oxosmoersyre eller salte deraf
NL7901220A (nl) Digesubstitueerde-3-cefem-4-carbonzuurverbindingen en werkwijzen ter bereiding daarvan.
DK129380A (da) Fremgangsmaade til fremstilling af 6,7-dialkoxy-1-piperidinophthalazin-forbindelser eller syreadditionssalte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed